title: Prevalence of the metabolic syndrome in the island of Gran Canaria: comparison of three major diagnostic proposals.
abstract: OBJECTIVE
  The present study was conducted to estimate the prevalence of the metabolic syndrome in a Canarian population, and to compare its frequency as defined by the most commonly used working definitions.
  
  
  METHODS
  Cross-sectional population-based study. One thousand and thirty adult subjects were randomly selected from the local census of Telde, a city located on the island of Gran Canaria. Participants completed a survey questionnaire and underwent physical examination, fasting blood analyses, and a 75-g standardized oral glucose tolerance test. The prevalence of the metabolic syndrome was estimated according to the definitions proposed by the World Health Organization (WHO), the European Group for the Study of Insulin Resistance (EGIR) and the National Cholesterol Education Program (NCEP), the latter with the original (6.1 mmol/l) and the revised criterion (5.6 mmol/l) for abnormal fasting glucose.
  
  
  RESULTS
  The adjusted prevalence of the metabolic syndrome was 28.0, 15.9, 23.0 and 28.2%, using the WHO, EGIR, NCEP and revised NCEP criteria, respectively. The measure of agreement (kappa statistic) was 0.57 between the WHO and the original NCEP definitions, and 0.61 between the WHO and the revised NCEP definitions. After excluding diabetic subjects, the agreement between the EGIR and WHO proposals was fairly good (kappa=0.70), whereas concordance of the EGIR with the original and the revised NCEP definitions was moderate (kappa=0.47 and 0.46, respectively).
  
  
  CONCLUSIONS
  Whichever the considered diagnostic criteria, the prevalence of the metabolic syndrome in this area of the Canary Islands is greater than that observed in most other European populations.
authors.affiliation: Section of Endocrinology and Nutrition, Hospital Universitario Insular, Las Palmas de Gran Canaria, Spain. mboronat@ctv.es
authors.forename: M
authors.initials: M
authors.lastname: Boronat
authors.forename: R
authors.initials: R
authors.lastname: Chirino
authors.forename: V F
authors.initials: VF
authors.lastname: Varillas
authors.forename: P
authors.initials: P
authors.lastname: Saavedra
authors.forename: D
authors.initials: D
authors.lastname: Marrero
authors.forename: M
authors.initials: M
authors.lastname: Fábregas
authors.forename: F J
authors.initials: FJ
authors.lastname: Nóvoa
mesh_terms: D000328:Adult; D000368:Aged; D001266:Atlantic Islands / Q000453:epidemiology; D001786:Blood Glucose / Q000032:analysis; D003430:Cross-Sectional Studies; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000453:epidemiology*; D008875:Middle Aged; D015995:Prevalence; D012016:Reference Values; D013030:Spain / Q000453:epidemiology
chemical_list: D001786:Blood Glucose